Astrazeneca boss pledges to boost drugs pipeline

The new boss of AstraZeneca today said the drugs giant must do more to bolster its product pipeline in the wake of a number of high-profile set-backs in clinical trials.

David Brennan declared the discovery of new medicines to be his “number one priority” since succeeding Tom McKillop as chief executive at the start of this year.